146 related articles for article (PubMed ID: 35120305)
1. Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
Alegria W; Marini BL; Gregg KS; Bixby DL; Perissinotti A; Nagel J
J Natl Compr Canc Netw; 2022 Feb; 20(3):245-252. PubMed ID: 35120305
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
[TBL] [Abstract][Full Text] [Related]
3. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
[No Abstract] [Full Text] [Related]
4. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
[TBL] [Abstract][Full Text] [Related]
6. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.
Gustinetti G; Raiola AM; Varaldo R; Galaverna F; Gualandi F; Del Bono V; Bacigalupo A; Angelucci E; Viscoli C; Mikulska M
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1721-1726. PubMed ID: 29578073
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
Tan X; Li Y; Xi J; Guo S; Su H; Chen X; Liang X
Medicine (Baltimore); 2021 Dec; 100(50):e27266. PubMed ID: 34918626
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
Horita N; Shibata Y; Watanabe H; Namkoong H; Kaneko T
Clin Microbiol Infect; 2017 Oct; 23(10):723-729. PubMed ID: 28377312
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
11. Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Crawford R; Perkins NB; Hobbs DA; Hobbs ALV
Pharmacotherapy; 2022 Oct; 42(10):798-805. PubMed ID: 36106434
[TBL] [Abstract][Full Text] [Related]
12. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
14. Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.
Fehér C; Rovira M; Soriano A; Esteve J; Martínez JA; Marco F; Carreras E; Martínez C; Fernández-Avilés F; Suárez-Lledó M; Mensa J
J Antimicrob Chemother; 2014 Sep; 69(9):2556-62. PubMed ID: 24855125
[TBL] [Abstract][Full Text] [Related]
15. A de-escalation protocol for febrile neutropenia cases and its impact on carbapenem resistance: A retrospective, quasi-experimental single-center study.
Alshukairi A; Alserehi H; El-Saed A; Kelta M; Rehman JU; Khan FA; Alsalmi H; Alattas M; Aslam M
J Infect Public Health; 2016; 9(4):443-51. PubMed ID: 26688375
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
[TBL] [Abstract][Full Text] [Related]
17. Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia.
Lucena M; Gaffney KJ; Urban T; Forbes C; Srinivas P; Majhail NS; Cober E; Mossad SB; Rybicki L; Hamilton BK
Clin Hematol Int; 2024; 6(1):59-66. PubMed ID: 38817693
[TBL] [Abstract][Full Text] [Related]
18. Nurse-initiated pre-prescribed antibiotic orders to facilitate prompt and appropriate antibiotic administration in febrile neutropenia.
Walker ST; Grigg S; Kirkpatrick C; Urbancic K; Cohen E; Grigg A; Trubiano J
Support Care Cancer; 2020 Sep; 28(9):4337-4343. PubMed ID: 31912358
[TBL] [Abstract][Full Text] [Related]
19. Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Ram R; Halavy Y; Amit O; Paran Y; Katchman E; Yachini B; Kor S; Avivi I; Ben-Ami R
Clin Infect Dis; 2018 Sep; 67(8):1153-1160. PubMed ID: 29608680
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial stewardship in high-risk febrile neutropenia patients.
Contejean A; Abbara S; Chentouh R; Alviset S; Grignano E; Gastli N; Casetta A; Willems L; Canouï E; Charlier C; Pène F; Charpentier J; Reboul-Marty J; Batista R; Bouscary D; Kernéis S
Antimicrob Resist Infect Control; 2022 Mar; 11(1):52. PubMed ID: 35346373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
